Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Vipul Jairath, Reena Khanna & Brian G. Feagan. (2017) Alicaforsen for the treatment of inflammatory bowel disease. Expert Opinion on Investigational Drugs 26:8, pages 991-997.
Read now
Read now
John K Triantafillidis, Emmanuel Merikas & Filippos Georgopoulos. (2011) Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Design, Development and Therapy 5, pages 185-210.
Read now
Read now
Articles from other publishers (18)
Yuqing Wu, Rajesh Jha, Ao Li, Huanwei Liu, Zeng Zhang, Chengcheng Zhang, Qixiao Zhai & Jiachao Zhang. (2022) Probiotics (Lactobacillus plantarum HNU082) Supplementation Relieves Ulcerative Colitis by Affecting Intestinal Barrier Functions, Immunity-Related Gene Expression, Gut Microbiota, and Metabolic Pathways in Mice. Microbiology Spectrum 10:6.
Crossref
Crossref
Xinyan Liu, Guangxu Xiao, Yule Wang, Ting Shang, Zhixiong Li, Huanyi Wang, Lihua Pu, Shuang He, Rui Shao, John Owoicho Orgah & Yan Zhu. (2022) Qishen Yiqi Dropping Pill facilitates post-stroke recovery of motion and memory loss by modulating ICAM-1-mediated neuroinflammation. Biomedicine & Pharmacotherapy 153, pages 113325.
Crossref
Crossref
Dimitrios Nikolakis, Floris A. E. de Voogd, Maarten J. Pruijt, Joep Grootjans, Marleen G. van de Sande & Geert R. D’Haens. (2022) The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences 23:3, pages 1854.
Crossref
Crossref
Ming-li Zhao, Tao Chen, Teng-hui Zhang, Feng Tian & Xiao Wan. (2021) H19 Overexpression Improved Efficacy of Mesenchymal Stem Cells in Ulcerative Colitis by Modulating the miR-141/ICAM-1 and miR-139/CXCR4 Axes. Disease Markers 2021, pages 1-14.
Crossref
Crossref
Triet M Bui, Hannah L Wiesolek & Ronen Sumagin. (2020) ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. Journal of Leukocyte Biology 108:3, pages 787-799.
Crossref
Crossref
Kirsten Deprey, Nefeli Batistatou & Joshua A Kritzer. (2020) A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics. Nucleic Acids Research 48:14, pages 7623-7639.
Crossref
Crossref
Honghui Zhou & Diane R. MouldSihem Ait-Oudhia, Yi Ting Kayla Lien, Sumit Basu, Lawrence Lesko & Stephan Schmidt. 2019. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases
209
242
.
Mark A. Samaan, Bo Shen, Mahmoud H. Mosli, Guangyong Zou, William J. Sandborn, Lisa M. Shackelton, Sigrid Nelson, Larry Stitt, Stuart Bloom, Darrell S. Pardi, Paolo Gionchetti, James Lindsay, Simon Travis, Ailsa Hart, Mark S. Silverberg, Brian G. Feagan, Geert R. D’Haens & Vipul Jairath. (2018) Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. Gastrointestinal Endoscopy 88:2, pages 360-369.e2.
Crossref
Crossref
Martina Traykovska, Sjoerd Miedema & Robert Penchovsky. (2018) Clinical Trials of Functional Nucleic Acids. International Journal of Biomedical and Clinical Engineering 7:2, pages 46-60.
Crossref
Crossref
Thomas Greuter, Stephan R. Vavricka, Luc Biedermann, Julia Pilz, Jan Borovicka, Frank Seibold, Bernhard Sauter & Gerhard Rogler. (2017) Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis. Digestive Diseases.
Crossref
Crossref
Lin Wang, Wei-Zhi Liu, Ling-Yan Pei, Yu-Shi Ke, Jian Cui & Shu-Chun Li. (2017) Garidisan: Improving the Quality of Ulcer Healing in Rats with Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-12.
Crossref
Crossref
Mahmoud H. Mosli, Jesus Rivera-Nieves & Brian G. Feagan. (2014) T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects. Drugs 74:3, pages 297-311.
Crossref
Crossref
Katja Christodoulou, Anthony E Wiskin, Jane Gibson, William Tapper, Claire Willis, Nadeem A Afzal, Rosanna Upstill-Goddard, John W Holloway, Michael A Simpson, R Mark Beattie, Andrew Collins & Sarah Ennis. (2013) Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut 62:7, pages 977-984.
Crossref
Crossref
H. L. Lightfoot & J. Hall. (2012) Target mRNA inhibition by oligonucleotide drugs in man. Nucleic Acids Research 40:21, pages 10585-10595.
Crossref
Crossref
Eva-Maria Collnot, Hussain Ali & Claus-Michael Lehr. (2012) Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. Journal of Controlled Release 161:2, pages 235-246.
Crossref
Crossref
A Lerner. (2012) Aluminum as an adjuvant in Crohn’s disease induction. Lupus 21:2, pages 231-238.
Crossref
Crossref
G. S. GuptaG. S. Gupta. 2012. Animal Lectins: Form, Function and Clinical Applications. Animal Lectins: Form, Function and Clinical Applications
991
1026
.
Johannes Winkler, Martina Stessl, Jennifer Amartey & Christian R. Noe. (2010) Off-Target Effects Related to the Phosphorothioate Modification of Nucleic Acids. ChemMedChem 5:8, pages 1344-1352.
Crossref
Crossref